Biomedical Structures Acquires Concordia Medical
Biomedical Structures LLC (BMS), Warwick, R.I. — a manufacturer of biomedical textiles for medical
devices and other clinical applications — has acquired Concordia Medical LLC — a provider of
medical implant technologies using biomaterials for tissue engineering and regenerative medicine,
and a division of Warwick-based engineered fiber producer Concordia Manufacturing LLC. The
acquisition includes Concordia Medical's workforce, manufacturing facility and technologies,
including its nonwoven BIOFELT™ technology for tissue-engineering and regenerative applications.
"With the acquisition of Concordia Medical, not only are we improving our biomedical textile engineering expertise and medical device market penetration, but we are increasing our manufacturing capacity to deliver on complex, sophisticated device applications at the volume our customers require," said John Gray, CEO and president, BMS. "The company is a terrific complement to our advanced scientific expertise in medical textiles and will help bring our production capabilities to the next level."
Concordia Manufacturing will continue to own a share of Concordia Medical, and Concordia Manufacturing CEO and President Randal Spencer will join BMS's Board of Directors and will be involved in the development of the combined company's business.
May/June 2011
"With the acquisition of Concordia Medical, not only are we improving our biomedical textile engineering expertise and medical device market penetration, but we are increasing our manufacturing capacity to deliver on complex, sophisticated device applications at the volume our customers require," said John Gray, CEO and president, BMS. "The company is a terrific complement to our advanced scientific expertise in medical textiles and will help bring our production capabilities to the next level."
Concordia Manufacturing will continue to own a share of Concordia Medical, and Concordia Manufacturing CEO and President Randal Spencer will join BMS's Board of Directors and will be involved in the development of the combined company's business.
May/June 2011
Advertisement



